Level Chart

Basic Info

Merck & Co. Inc. (MRK) - Pharmaceutical Revenue is at a current level of 53.58B, up from 52.00B one year ago. This is a change of 3.03% from one year ago.

Pharmaceutical Revenue refers to the total revenue generated by Merck from the sale of its pharmaceutical products. This includes revenue from prescription drugs, over-the-counter medications, vaccines, and other pharmaceutical products developed and marketed by the company.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 53.58B
Latest Period 2023
Last Updated Feb 15 2024, 08:46 EST
Next Release Feb 15 2025, 08:30 EST (E)
Average Growth Rate 2.96%
Value from 1 Year Ago 52.00B
Change from 1 Year Ago 3.03%
Frequency Yearly
Unit USD
Adjustment N/A

Historical Data

View and export this data back to 2012. Upgrade now.
Date Value
December 31, 2023 53.58B
December 31, 2022 52.00B
December 31, 2021 42.75B
December 31, 2020 36.61B
December 31, 2019 34.10B
December 31, 2018 37.69B
Date Value
December 31, 2017 35.39B
December 31, 2016 35.15B
December 31, 2015 34.78B
December 31, 2014 36.04B
December 31, 2013 37.44B
December 31, 2012 40.60B

Basic Info

Merck & Co. Inc. (MRK) - Pharmaceutical Revenue is at a current level of 53.58B, up from 52.00B one year ago. This is a change of 3.03% from one year ago.

Pharmaceutical Revenue refers to the total revenue generated by Merck from the sale of its pharmaceutical products. This includes revenue from prescription drugs, over-the-counter medications, vaccines, and other pharmaceutical products developed and marketed by the company.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 53.58B
Latest Period 2023
Last Updated Feb 15 2024, 08:46 EST
Next Release Feb 15 2025, 08:30 EST (E)
Average Growth Rate 2.96%
Value from 1 Year Ago 52.00B
Change from 1 Year Ago 3.03%
Frequency Yearly
Unit USD
Adjustment N/A

Related Securities

Symbol Name Change %
MRK Merck & Co Inc -1.72%